ClinicalTrials.gg
Active, not recruitingNCT07881042NEURO-TEAUpdated Oct 19, 2026

Transition From Pediatric to Adult Care in Young Adults With Acquired Brain Injury

An observational study in Acquired Brain Injury, sponsored by Hopitaux de Saint-Maurice. Active, not recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Hopitaux de Saint-Maurice · Observational

Updated Oct 19, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
72
Ages
18 Years and older
Sex
All
01

Study summary

This retrospective, single-center observational study evaluates young adults with acquired brain injury who attended a joint pediatric-adult Physical and Rehabilitation Medicine transition consultation at Hôpitaux Paris Est Val-de-Marne between January 2022 and January 2026. The study aims to describe their clinical, functional, neuropsychological, and psychosocial characteristics and to identify vulnerability factors potentially associated with disruption of follow-up during the transition to adult care. Data are retrospectively collected from medical records and consultation reports.

Read the detailed description

Transition from pediatric to adult healthcare represents a vulnerable period for adolescents and young adults with chronic conditions, particularly for individuals with acquired brain injury who may present persistent motor, cognitive, behavioral, neuropsychological, and psychosocial impairments.

This retrospective single-center study analyzes joint pediatric-adult Physical and Rehabilitation Medicine transition consultations performed at Hôpitaux Paris Est Val-de-Marne between January 1, 2022 and January 31, 2026.

The study population includes young adults over 18 years of age with acquired brain injury occurring during childhood or adolescence who attended at least one joint transition consultation and for whom medical records and consultation reports are available.

Retrospectively collected data include demographic characteristics, medical history, type of acquired brain injury, associated conditions, motor and cognitive impairments, neuropsychological findings, educational and professional status, autonomy, family support, living conditions, and medico-social orientation.

The primary objective is to describe the clinical, functional, neuropsychological, and psychosocial characteristics of this population at the time of transition to adult care. Secondary objectives include identifying vulnerability factors potentially associated with disruption of follow-up, describing specific needs during the transition period, and informing optimization of the current transition care model.

02

Conditions studied

  • Acquired Brain Injury

Browse trials for

Keywords

  • acquired brain injury
  • transition to Adult Care
  • Physical and Rehabilitation Medicine
  • Continuity of care
  • young adults
  • Follow-up Discontinuation
03

In context

Brain Injuries

2,125 studies on the registry are indexed under Brain Injuries; 384 are open to participants now.

This study's enrollment of 72 is below the median of 100 across 692 observational studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

Hopitaux de Saint-Maurice is the lead sponsor of 16 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of young adults with acquired brain injury occurring during childhood or adolescence who received care within the joint pediatric-adult Physical and Rehabilitation Medicine transition program at Hôpitaux Paris Est Val-de-Marne.

All patients who attended at least one joint transition consultation between January 1, 2022 and January 31, 2026 and who met the study eligibility criteria were identified retrospectively from medical records and consultation reports. The study is based on routinely collected clinical data from this transition care pathway.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Young adults with an acquired brain injury that occurred during childhood or adolescence;
  • Who have attended at least one paediatric-to-adult rehabilitation transition consultation at the HPEVM between 1 January 2022 and 31 January 2026;
  • For whom medical records and consultation reports are available.

Exclusion criteria

Exclusion Criteria:

  • Lack of usable medical records
  • Patients not being monitored as part of the joint consultation
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
72 participants (actual)
Patient registry
No

Groups and cohorts

  • Young adults with acquired brain injury

    Young adults aged over 18 years with acquired brain injury occuring during children or adolescence who attended at least one joint pediatric-adult physical dans rehabilitation medicine transition consultation at Hôpitaux Paris Est Val-de-Marne between January 1, 2022 dans January 31, 2026.

06

What researchers measure

Primary outcomes

  1. Number of Participants by Clinical and Functional Characteristic

    Number of participants according to clinical and functional characteristics documented in medical records and transition consultation reports, including type of acquired brain injury, associated medical conditions, motor impairments, and cognitive or neuropsychological impairments.

    Time frame: Baseline (first joint pediatric-adult transition consultation)

  2. Educational and employment status

    Educational and employment characteristics, including level of education, school or university accommodations, and current employment status.

    Time frame: At the joint pediatric-adult transition consultation, retrospectively assessed from consultations performed between January 2022 and January 2026.

  3. Number of Participants by Psychosocial and Environmental Characteristic

    Number of participants according to psychosocial and environmental characteristics documented in medical records and transition consultation reports, including autonomy, family support, living conditions, lifestyle, and medico-social orientation.

    Time frame: aseline (first joint pediatric-adult transition consultation)

Secondary outcomes

  1. Number of Participants With Vulnerability Factors at Transition to Adult Care

    Number of participants with documented vulnerability factors at transition to adult care, based on medical records and transition consultation reports. Factors may include cognitive or motor impairments, reduced autonomy, limited family support, adverse living conditions, and educational or employment difficulties.

    Time frame: Baseline (first joint pediatric-adult transition consultation)

07

Study locations

1 site
  • Hôpitaux Paris Est Val-de-Marne - Unité de transition Enfants Adultes
    Saint-Maurice, 94410, France
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because this is a retrospective, single-center study based on routinely collected medical record data containing sensitive clinical and psychosocial information. The dataset is pseudonymized and access is restricted to authorized study personnel in accordance with applicable data protection requirements. Only aggregated, non-identifiable results will be reported in publications or presentations.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2026 to primary completion in Sep 2026, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 19, 2026
StartActual
Jul 1, 2026
Primary completionActual
Sep 1, 2026
CompletionEst.
Dec 2026
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07881042
Lead sponsor
Hopitaux de Saint-Maurice
Responsible party
Sponsor
First posted
Oct 19, 2026
Start date
Jul 1, 2026
Primary completion
Sep 1, 2026
Completion
Dec 2026 (estimated)
Last update
Oct 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion